~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Trilogy Tidings
March 2011
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
in this issue
Leverage Cost Effectiveness Now
Clinical Studies: Early and Often
Surgical Simulation and More
Resources from our Archives
What does Trilogy do?

     The importance of product cost effectiveness - to our healthcare system and our medical-product suppliers - is not going away.  Quite the contrary, and the evidence mounts.  I start with a reprise of this issue from my initial thoughts shared earlier.

     When should your medical device undergo a clinical study, and why?  I touch on this subject, and reveal a new Internet resource, next.

     Finally, a clever simulation tool for surgical training, and perhaps more.

Regards,
Joe

 

 

 Change Ahead

 

 

Leverage Cost Effectiveness Now 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Medical CostsA recently reported presentation by academic researcher David Meltzer at the annual meeting of AAAS caught my eye.  He was pitching the importance of cost-effectiveness analysis in controlling healthcare costs.  His emphasis on reducing the frequency of medical tests is greater than I would advocate.  Nevertheless, this article reminded me of just how important - to medical product suppliers - the issue of cost has become.  I'm not talking about product price here; the issue is much more profound than that.

     No matter which end of the political spectrum "wins" the current debate, cost effectiveness will become the arbiter of market winners and market losers.  Either a government will impose limits and proof requirements or industry and healthcare providers will, of necessity, be compelled to address societal costs to compete.  Suppliers and providers simply must leverage cost effectiveness now or be left in the dust over the next decade.

     I addressed the cost effectiveness issue in a white paper in November of 2009, and recent events convince me that the issue is even more important - and more urgent - now.  Have a look at those thoughts, and let me know what you think.

Clinical Studies: Early and Often 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Clinical StudiesI discovered a new Web site called Healing Innovation; more on that later.  A recent post on that site addressed the importance of early and frequent clinical studies in a very convincing manner.  One's first reaction is likely to be:  "I can barely afford one trial, how can I possibly afford many?"  But the author makes a strong case for early, small pilot and feasibility studies for purposes of design and procedural improvements prior to a definitive clinical trial (if such a trial is required at all).  This post will cause you to think beyond regulatory requirements as a reason for explorations in the clinic.

     The Healing Innovation site appears to be a source of information for physicians and other clinicians who are disposed to invent new devices and therapies.  It aims to provide resources to assist their commercialization efforts.  All is not clear because the producers of the site are not identified, so I'll reserve judgment for now.  But it's worth a look.
Surgical Simulation and More 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Surgical SimulationA recent article in the Boston Globe describes the products and business of a small Massachusetts company (Chamberlain Group) that provides simulated body parts to medical schools and device makers for surgical training and surgical-tool testing.  These silicone parts are replicas apparently quite good enough for training medical students and residents at some name-brand schools.  Some leading suppliers - including Boston Scientific and J&J - use these squishy models in large numbers for various purposes.  (Chamberlain has grown to 20 employees and acquired some rather fancy 3D printers and design software since 1999.)

     I find the prospect of using models such as these for uses beyond surgeon training intriguing.  Consider product demos to support sales efforts.  Or body-part simulators for proof-of-concept studies.  Or employee training aids.  Or realistic investor pitches (maybe not!).

Resources from our Archives 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
     Check out our Reading Room to view my published articles, presentations and white papers on a variety of topics.

 

     And, you can examine an archive of my prior newsletters (since February 2007).

 

What does Trilogy do? 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
     Trilogy Associates facilitates business growth and renewal through commercialization of new products, providing the following services:
  • Opportunity assessment
  • Business planning and enterprise growth strategies
  • New-product conceptualization, commercialization and marketing
  • Market research and competitive assessment
  • Business development and partnering
  • Market and technological due diligence
  • Assessment of the therapeutic and diagnostic potential of novel technologies
  • Design of efficient and effective development strategies for early-stage biomedical products
  • Business and technical writing/publishing

     Inquiries to establish whether and how we might support your business initiatives are always welcome.  Contact us.  And check out our partner, Innovalyst, A Catalyst for Innovation.

Contact Information
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
ContactInfoJoseph J. Kalinowski, Principal
919.533.6285
LinkedIn Profile: www.linkedin.com/in/trilogy
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~